Active, not recruitingNot applicableNCT07162623

Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects With Facial Dark Spots Such as Pimple Marks, Sunspots, Age Spots and Uneven Skin Tone

Studying Hyperpigmentation of the skin

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NovoBliss Research Pvt Ltd
Principal Investigator
Nayan Patel
NovoBliss Research Pvt Ltd
Intervention
Oziva Bioactive Gluta Fizzy Effervescent Tablets 4.1 g containing Glutathione(other)
Enrollment
60 target
Eligibility
21-55 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Collaborators

Zywie Ventures Pvt Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07162623 on ClinicalTrials.gov

Other trials for Hyperpigmentation of the skin

Additional recruiting or active studies for the same condition.

See all trials for Hyperpigmentation of the skin →

← Back to all trials